Skip to main content
. 2002 Sep;40(9):3155–3161. doi: 10.1128/JCM.40.9.3155-3161.2002

FIG. 1.

FIG. 1.

Prevalence of any HPV type, any high-risk HPV type, any low-risk HPV DNA type, or the presence of a multiple infection in urine or cervix for entire study population of 101 HIV-positive women. The amplifiability of HPV DNA from urine and cervical swab specimens is also compared in the first column. White bars, urine samples; thatched bars, cervical swab samples. Significant differences are denoted by an asterisk (P < 0.05).